Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

BACKGROUND: Human epidermal growth factor receptor 2 (HER2)-positive tumors are defined by protein overexpression (3+) or gene amplification using immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH), respectively. HER2-positive tumors have historically included both IHC(3+) and I...

Descripción completa

Detalles Bibliográficos
Autores principales: Horimoto, Yoshiya, Ishizuka, Yumiko, Ueki, Yuko, Higuchi, Toru, Arakawa, Atsushi, Saito, Mitsue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897871/
https://www.ncbi.nlm.nih.gov/pubmed/35248011
http://dx.doi.org/10.1186/s12885-022-09351-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897871/
https://www.ncbi.nlm.nih.gov/pubmed/35248011
http://dx.doi.org/10.1186/s12885-022-09351-4

Ejemplares similares